Terms: = Bone cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
19 results:
1. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency treatment Consortium.
Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Targeted Next-Generation Panel Sequencing Reveals
Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
[TBL] [Abstract] [Full Text] [Related]
3. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
4. A deep belief network-based clinical decision system for patients with osteosarcoma.
Li W; Dong Y; Liu W; Tang Z; Sun C; Lowe S; Chen S; Bentley R; Zhou Q; Xu C; Li W; Wang B; Wang H; Dong S; Hu Z; Liu Q; Cai X; Feng X; Zhao W; Yin C
Front Immunol; 2022; 13():1003347. PubMed ID: 36466868
[TBL] [Abstract] [Full Text] [Related]
5. Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ) 2.0 with its assessment in clinical setting.
Yin M; Sun Z; Ding X; Wang T; Sun Y; Li L; Gao X; Ma J; Huang Q; Xiao J; Mo W
Spine J; 2022 Dec; 22(12):2024-2032. PubMed ID: 36031097
[TBL] [Abstract] [Full Text] [Related]
6. Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events.
Ailawadhi S; Medhekar R; Princic N; Fowler R; Tran O; Bhowmik D; Panjabi S
J Oncol Pharm Pract; 2020 Jul; 26(5):1070-1079. PubMed ID: 31631810
[TBL] [Abstract] [Full Text] [Related]
7. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Schöffski P; Wozniak A; Escudier B; Rutkowski P; Anthoney A; Bauer S; Sufliarsky J; van Herpen C; Lindner LH; Grünwald V; Zakotnik B; Lerut E; Debiec-Rychter M; Marréaud S; Lia M; Raveloarivahy T; Collette S; Albiges L
Eur J Cancer; 2017 Dec; 87():147-163. PubMed ID: 29149761
[TBL] [Abstract] [Full Text] [Related]
8. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract] [Full Text] [Related]
9. A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
Dorris K; Liu C; Li D; Hummel TR; Wang X; Perentesis J; Kim MO; Fouladi M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654490
[TBL] [Abstract] [Full Text] [Related]
10. Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer.
Jayasekera J; Onukwugha E; Bikov K; Hussain A
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):471-85. PubMed ID: 25817559
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.
Yang JL
Chin J Cancer; 2014 Dec; 33(12):575-80. PubMed ID: 25418192
[TBL] [Abstract] [Full Text] [Related]
12. Recurrent LRP1-SNRNP25 and KCNMB4-ccnd3 fusion genes promote tumor cell motility in human osteosarcoma.
Yang J; Annala M; Ji P; Wang G; Zheng H; Codgell D; Du X; Fang Z; Sun B; Nykter M; Chen K; Zhang W
J Hematol Oncol; 2014 Oct; 7():76. PubMed ID: 25300797
[TBL] [Abstract] [Full Text] [Related]
13. [Surgical treatment of bone metastases from renal cell carcinoma].
Wang H; Zhou N; Xu X; Zhai J; Zhu X; Li G; Wang J; Liu N; He F; Wang H; Huang G; Man L
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):289-92. PubMed ID: 24731497
[TBL] [Abstract] [Full Text] [Related]
14. Late mortality and second cancers in an Australian cohort of childhood cancer survivors.
Wilson CL; Cohn RJ; Johnston KA; Ashton LJ
Med J Aust; 2010 Sep; 193(5):258-61. PubMed ID: 20819041
[TBL] [Abstract] [Full Text] [Related]
15. Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
Mauri D; Valachis A; Polyzos NP; Tsali L; Mavroudis D; Georgoulias V; Casazza G
J Natl Compr Canc Netw; 2010 Mar; 8(3):279-86. PubMed ID: 20202461
[TBL] [Abstract] [Full Text] [Related]
16. CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.
Hsi ED; Steinle R; Balasa B; Szmania S; Draksharapu A; Shum BP; Huseni M; Powers D; Nanisetti A; Zhang Y; Rice AG; van Abbema A; Wong M; Liu G; Zhan F; Dillon M; Chen S; Rhodes S; Fuh F; Tsurushita N; Kumar S; Vexler V; Shaughnessy JD; Barlogie B; van Rhee F; Hussein M; Afar DE; Williams MB
Clin Cancer Res; 2008 May; 14(9):2775-84. PubMed ID: 18451245
[TBL] [Abstract] [Full Text] [Related]
17. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract] [Full Text] [Related]
18. Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects.
Brouwer C; Vermunt-de Koning DG; Trueworthy RC; Ter Riet PG; Duley JA; Trijbels FJ; Hoogerbrugge PM; Bökkerink JP; van Wering ER; De Abreu RA
Pediatr Blood Cancer; 2006 Apr; 46(4):434-8. PubMed ID: 16333815
[TBL] [Abstract] [Full Text] [Related]
19. External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes.
Akimoto T; Kitamoto Y; Saito J; Harashima K; Nakano T; Ito K; Yamamoto T; Kurokawa K; Yamanaka H; Takahashi M; Mitsuhashi N; Niibe H
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):372-9. PubMed ID: 15145150
[TBL] [Abstract] [Full Text] [Related]
